425: Acuren and NV5 Global Advance Merger Amid Shareholder Lawsuits and Supplemental Disclosures

Acuren Corporation and NV5 Global, Inc. have filed a supplement to their definitive proxy statement, providing updates on their pending merger, including the expiration of the go-shop period and the emergence of shareholder lawsuits alleging material omissions.

Summary

• This filing is a supplement to the Definitive Proxy Statement filed by NV5 Global, Inc. on July 2, 2025, and the joint proxy statement/prospectus filed by Acuren Corporation on July 1, 2025.
• The supplement relates to the Agreement and Plan of Merger entered into on May 14, 2025, between NV5, Acuren, Ryder Merger Sub I, Inc., and Ryder Merger Sub II, Inc.
• The merger involves a two-step process: Merger Sub I will merge into NV5, and immediately thereafter, the surviving NV5 will merge into Merger Sub II.
• NV5's special meeting of stockholders is scheduled for July 31, 2025.
• Premerger notification and report forms under the HSR Act were filed on June 12, 2025, and the waiting period expired at 11:59 p.m., Eastern Time, on July 14, 2025.
• The 60-day go-shop period under the Merger Agreement expired on July 14, 2025, during which NV5 did not receive an 'NV5 Superior Proposal'.
• Acuren and NV5 currently expect to complete the Merger in August of 2025, subject to required stockholder and regulatory approvals and other conditions.
• NV5 has received several demand letters and two lawsuits (Williams v. NV5 Global, Inc., et al. filed July 8, 2025, and Miller v. NV5 Global, Inc., et al. filed July 9, 2025) from purported stockholders alleging material omissions in the Definitive Proxy Statement.
• NV5 denies these allegations but is providing supplemental disclosures solely to moot the claims and minimize litigation risk, without admitting liability or wrongdoing.
• Supplemental disclosures include details on confidentiality agreements entered into by NV5 with Party A on May 16, 2025, and Party B on May 17, 2025.
• Acuren delivered a revised, non-binding indication of interest to the NV5 Board on March 12, 2025, to acquire all outstanding shares of NV5 Common Stock for $23.00 per share, consisting of $10.00 cash and 1.08 shares of Acuren Common Stock.
• Baird's opinion analysis for NV5 and Acuren, including selected public company analysis, selected transaction analysis, and discounted cash flow analysis, was supplemented with additional details and calculations.
• As of the date of this supplement, none of NV5's named executive officers have entered into new agreements or substantive discussions with Acuren regarding post-merger compensation or employment, beyond the Merger Agreement's provisions for equity awards.

Sentiment

Score: 4

Explanation: While the merger is progressing with HSR clearance and no superior proposal, the emergence of shareholder lawsuits alleging material omissions introduces significant legal and reputational risks, potentially increasing costs and uncertainty for the transaction.

Positives

• The 60-day go-shop period for NV5 expired on July 14, 2025, without NV5 receiving a 'Superior Proposal,' indicating the Acuren merger remains the primary path forward.
• The waiting period under the HSR Act expired on July 14, 2025, removing a significant regulatory hurdle for the merger.
• Acuren and NV5 currently expect to complete the Merger in August of 2025, indicating the transaction timeline is still on track.

Negatives

• NV5 has received several demand letters from purported stockholders alleging material omissions in the Definitive Proxy Statement, claiming violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934.
• Two lawsuits, Williams v. NV5 Global, Inc., et al. (filed July 8, 2025) and Miller v. NV5 Global, Inc., et al. (filed July 9, 2025), have been filed by purported stockholders alleging substantially similar claims.
• NV5 is providing supplemental disclosures solely to moot the claims and minimize litigation risk, costs, burden, nuisance, and uncertainties, despite believing no further disclosure is legally required, which indicates an unexpected legal challenge.

Risks

• The possibility that stockholders of NV5 may not approve the Merger Agreement.
• The possibility that stockholders of Acuren may not approve the issuance of new shares of Acuren Common Stock in the Merger.
• The risk that a condition to closing of the Merger may not be satisfied, or that either party may terminate the Merger Agreement, or that the Closing might be delayed or not occur at all.
• Potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the Merger.
• The diversion of management time on transaction-related issues.
• The ultimate timing, outcome, and results of integrating the operations of NV5 and Acuren.
• The effects of the business combination of NV5 and Acuren, including the combined company's future financial condition, results of operations, strategy, and plans.
• The ability of the combined company to realize anticipated synergies in the timeframe expected or at all.
• Changes in capital markets and the ability of the combined company to finance operations in the manner expected.
• Regulatory approval of the transaction.
• The effects of commodity prices.
• Risks related to the demand for Acuren and NV5's services.
• Operating costs and business disruption may be greater than expected following the public announcement or consummation of the Merger.

Future Outlook

Acuren and NV5 currently expect to complete the Merger in August of 2025, subject to the receipt of required stockholder and regulatory approvals and the satisfaction or waiver of other conditions set forth in the Merger Agreement. The combined company aims to realize anticipated synergies, though the timing and extent are subject to various risks, including changes in capital markets and demand for services.

Management Comments

• NV5 believes that no further disclosure is required to supplement the Definitive Proxy Statement under applicable laws.
• Solely to moot the claims in the Demand Letters and Complaints and minimize the risk, costs, burden, nuisance and uncertainties inherent in litigation, and without admitting any liability or wrongdoing, NV5 hereby supplements the disclosures contained in the Definitive Proxy Statement.
• NV5 vigorously denies all allegations in the Demand Letters and the Complaints, including that any additional disclosure was or is required, and believes that the supplemental disclosures contained herein are immaterial.

Industry Context

The merger between Acuren and NV5 Global, both operating in the engineering, environmental consulting, and testing/inspection/certification sectors, reflects ongoing consolidation and strategic alignment within these industries. Baird's analysis references a range of publicly traded companies and past acquisition transactions, indicating a dynamic M&A landscape driven by factors such as enterprise value multiples (EV/Adjusted EBITDA, EV/Adjusted EBIT) and strategic growth opportunities.

Comparison to Industry Standards

• Baird's Selected Public Company Analysis for engineering and environmental consulting companies (e.g., AECOM, Jacobs Solutions Inc., WSP Global Inc.) showed EV/Adjusted EBITDA multiples ranging from 8.2x to 16.9x (LTM) and 7.3x to 15.1x (2025E).
• Baird's Selected Public Company Analysis for testing, inspection, and certification companies (e.g., Bureau Veritas SA, SGS S.A.) showed EV/Adjusted EBITDA multiples ranging from 5.3x to 14.3x (LTM) and 5.2x to 13.4x (2025E).
• Baird's Selected Transaction Analysis for completed acquisitions in the sector (e.g., BCC Engineering, LLC by Parsons Corporation at 13.0x LTM EBITDA; Power Engineers, Incorporated by WSP Global Inc. at 15.2x LTM EBITDA) showed EV/LTM EBITDA multiples ranging from 10.4x to 15.2x.
• NV5's implied per share equity values from selected transaction analysis ranged from $20.32 to $30.97 (based on Adjusted EBITDA) and $14.86 to $27.07 (based on Adjusted EBIT), with the Merger Consideration at $23.00 per share, falling within these ranges.
• NV5's implied range of values from DCF analysis was $18.28 to $29.31 per share, also encompassing the $23.00 merger consideration.
• Acuren's implied range of values from DCF analysis was $7.90 to $13.15 per share, compared to its then-current price of $10.64 per share.

Legal Proceedings

• Several demand letters from purported NV5 stockholders alleging material omissions in the Definitive Proxy Statement, violating Sections 14(a) and 20(a) of the Securities Exchange Act of 1934, and seeking NV5 books and records.
• Complaint filed on July 8, 2025, in the Supreme Court of the State of New York, County of New York, captioned Williams v. NV5 Global, Inc., et al., alleging substantially similar claims.
• Complaint filed on July 9, 2025, in the Supreme Court of the State of New York, County of New York, captioned Miller v. NV5 Global, Inc., et al., alleging similar claims.

Stakeholder Impact

• Shareholders of NV5 are subject to a merger vote and face potential impacts from ongoing litigation regarding the Definitive Proxy Statement, which could affect merger terms or timing.
• Shareholders of Acuren are subject to a vote on the issuance of new shares for the merger and will be impacted by the combined entity's performance.
• Management and employees of NV5 may enter into new employment agreements or amendments with the combined company after the Merger, affecting their future roles and compensation.

Next Steps

• NV5's special meeting of stockholders is scheduled for July 31, 2025, to approve the Merger Agreement.
• Acuren stockholders are expected to approve the issuance of new shares of Acuren Common Stock in the Merger.
• Completion of the Merger is expected in August 2025, subject to approvals and satisfaction of conditions.
• Potential for NV5's named executive officers to enter into new employment agreements or amendments with the combined company after the Merger.

Key Dates

Recommendation

Keywords

SEC filing, Merger Agreement, NV5 Global Inc., Acuren Corporation, Proxy Statement, Shareholder Lawsuit, HSR Act, Go-Shop Period, Financial Analysis, Valuation, Corporate Governance, Risk Management, Acquisition, Engineering Consulting, Environmental Consulting, Testing Inspection Certification